State Street’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,797,916
Closed -$66.1M 4427
2023
Q4
$66.1M Buy
2,797,916
+511,972
+22% +$12.1M ﹤0.01% 1549
2023
Q3
$34.1M Sell
2,285,944
-22,549
-1% -$336K ﹤0.01% 1842
2023
Q2
$25.3M Buy
2,308,493
+1,639,457
+245% +$18M ﹤0.01% 2097
2023
Q1
$5.83M Buy
669,036
+330,763
+98% +$2.88M ﹤0.01% 2934
2022
Q4
$2.12M Hold
338,273
﹤0.01% 3358
2022
Q3
$1.18M Sell
338,273
-23,847
-7% -$83.5K ﹤0.01% 3564
2022
Q2
$1.07M Sell
362,120
-995,930
-73% -$2.94M ﹤0.01% 3618
2022
Q1
$4.22M Buy
1,358,050
+24,160
+2% +$75.1K ﹤0.01% 3268
2021
Q4
$4.51M Buy
1,333,890
+56,923
+4% +$192K ﹤0.01% 3287
2021
Q3
$4.66M Sell
1,276,967
-80,257
-6% -$293K ﹤0.01% 3274
2021
Q2
$5.92M Buy
1,357,224
+66,378
+5% +$289K ﹤0.01% 3169
2021
Q1
$5.86M Sell
1,290,846
-517,501
-29% -$2.35M ﹤0.01% 2978
2020
Q4
$10.4M Buy
1,808,347
+167,833
+10% +$963K ﹤0.01% 2609
2020
Q3
$11.9M Buy
1,640,514
+226,043
+16% +$1.64M ﹤0.01% 2351
2020
Q2
$4.94M Sell
1,414,471
-7,095
-0.5% -$24.8K ﹤0.01% 2761
2020
Q1
$2.1M Buy
1,421,566
+11,652
+0.8% +$17.2K ﹤0.01% 3049
2019
Q4
$2.76M Sell
1,409,914
-171,539
-11% -$336K ﹤0.01% 3129
2019
Q3
$8.1M Sell
1,581,453
-24,881
-2% -$127K ﹤0.01% 2571
2019
Q2
$11.5M Buy
1,606,334
+341,579
+27% +$2.45M ﹤0.01% 2437
2019
Q1
$16.8M Sell
1,264,755
-17,640
-1% -$234K ﹤0.01% 2156
2018
Q4
$10.1M Sell
1,282,395
-32,835
-2% -$258K ﹤0.01% 2427
2018
Q3
$14.6M Sell
1,315,230
-6,333
-0.5% -$70.2K ﹤0.01% 2384
2018
Q2
$17.7M Buy
1,321,563
+1,087,773
+465% +$14.6M ﹤0.01% 2212
2018
Q1
$3.04M Buy
233,790
+189,268
+425% +$2.46M ﹤0.01% 3003
2017
Q4
$409K Buy
44,522
+9,822
+28% +$90.2K ﹤0.01% 3477
2017
Q3
$279K Buy
+34,700
New +$279K ﹤0.01% 3564